Jacobson Pharma Corporation Limited Financial Overview
Jacobson Pharma Corporation Limited's market cap is currently HK$2.45B. The company's EPS TTM is HK$0.071; its P/E ratio is 8.49; and it has a dividend yield of 15.16%. Jacobson Pharma Corporation Limited is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
